Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma?

被引：11
|
作者：
Phipps, RP
Ryan, E
Bernstein, SH
机构：
[1] Univ Rochester, Sch Med & Dent, Dept Environm Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA
[2] James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
LEUKEMIA RESEARCH | 2004年 / 28卷 / 02期
关键词：
cyclooxygenase-2; B-cell lymphoma; prostaglandin (PG);
D O I：
10.1016/S0145-2126(03)00260-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The purpose of this editorial is to highlight the findings reported herein in the paper by Wun et al. on the connection between expression of the cyclooxygenase-2 (COX-2) enzyme and B-cell lymphoma [Leuk. Res., in press]. We will first briefly review key aspects of the COX-2 enzyme, the newly discovered prostaglandin (PG) sypthases and their PG products, and their roles both in inflammation and in the pathogenesis of cancer. Having placed the COX pathway in this context, the discussion will then return to the provocative findings of Wun et al. [Leuk. Res., 28, 2004]. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [1] Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma
    Li, Zhongxing
    Ge, Guangcheng
    Feng, Rui
    Wu, Dan
    Shen, Bin
    Wang, Xing
    Cui, Yan
    Li, Junrong
    Ju, Xiaobing
    BMC UROLOGY, 2014, 14
  • [2] Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma
    Zhongxing Li
    Guangcheng Ge
    Rui Feng
    Dan Wu
    Bin Shen
    Xing Wang
    Yan Cui
    Junrong Li
    Xiaobing Ju
    BMC Urology, 14
  • [3] Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma
    Cui, Yingying
    Sun, Zhenchang
    Li, Xin
    Leng, Changsen
    Zhang, Lei
    Fu, Xiaorui
    Li, Ling
    Zhang, Xudong
    Chang, Yu
    Nan, Feifei
    Li, Zhaoming
    Yan, Jiaqin
    Zhang, Mingzhi
    Li, Wencai
    Wang, Guannan
    Zhang, Dandan
    Ma, Yaozhen
    ONCOLOGY LETTERS, 2016, 11 (01) : 693 - 698
  • [4] Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
    Sheng, HM
    Shao, JY
    Kirkland, SC
    Isakson, P
    Coffey, RJ
    Morrow, J
    Beauchamp, RD
    DuBois, RN
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) : 2254 - 2259
  • [5] Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib
    Nam, DH
    Park, K
    Park, C
    Im, YH
    Kim, MH
    Lee, S
    Hong, SC
    Shin, HJ
    Kim, JH
    Eoh, W
    McDonnell, TJ
    ONCOLOGY REPORTS, 2004, 11 (02) : 263 - 268
  • [6] Jadomycin B Causes Human Breast Cancer Cell Death Through Inhibition of Cyclooxygenase-2 Signalling
    McKeown, Brendan T.
    Goralski, Kerry B.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 102 (04) : 9 - 9
  • [7] Relationship between cyclooxygenase-2 inhibition and thrombogenesis
    Dai, WD
    Kloner, RA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 9 (01) : 51 - 59
  • [8] CAR T-cell therapy for B-cell lymphoma
    Denlinger, Nathan
    Bond, David
    Jaglowski, Samantha
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [9] Why cyclooxygenase-2 inhibition plus chemotherapy?
    Sweeney, CJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S122 - S125
  • [10] Cancer and cyclooxygenase-2 (COX-2) inhibition
    Evans, JF
    Kargman, SL
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 627 - 634
12345